Investor List:

Top Digital Health Series B Investors in Canada (12)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Digital Health investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of James C. Murray, Partner at ExSight Capital Management
James C. Murray
Sweet spot: $1M
Range: $200K - $4.0M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Robotics (Pre-seed), Investors in Hardware (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Hardware (Pre-seed), Investors in Robotics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Medical Devices (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Health & Hospital Services (Seed), Investors in Digital Health (Seed), Investors in Hardware (Seed), Investors in Therapeutics (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Drug Delivery (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Digital Health (Series A), Investors in Hardware (Series A), Investors in Medical Devices (Series A), Investors in Therapeutics (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Robotics (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Hardware (Series A), Investors in Robotics (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series B), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Series B), Investors in Hardware (Series B), Investors in Medical Devices (Series B), Investors in Therapeutics (Series B), Investors in Diagnostics (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Therapeutics (Series B), Investors in Robotics (Series B), Investors in Drug Delivery (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Hardware (Series B), Investors in Robotics (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Canada (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists)
Photo of Shalva Gozland, Investor at Insight Partners
Shalva Gozland
Sweet spot: $10.0M
Range: $50K - $1.0B
Investors in New Zealand, Investors in Australia, Investors in Canada, Investors in Europe, Investors in Israel, Investors in United States
Investors in Generative Tech/AI (Pre-seed), Investors in AutoTech (Pre-seed), Investors in Enterprise Applications (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in AutoTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Enterprise Applications (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in AutoTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in Enterprise (Pre-seed), Investors in SaaS (Pre-seed), Investors in SaaS (Pre-seed), Investors in Enterprise (Pre-seed), Investors in AI (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Enterprise Applications (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in Enterprise (Pre-seed), Investors in SaaS (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in AutoTech (Seed), Investors in Consumer Health (Seed), Investors in Enterprise Applications (Seed), Investors in AutoTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Generative Tech/AI (Seed), Investors in Enterprise Applications (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in AutoTech (Seed), Investors in AI (Seed), Investors in Enterprise (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed), Investors in SaaS (Seed), Investors in AI (Seed), Investors in Generative Tech/AI (Seed), Investors in Digital Health (Seed), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Enterprise Applications (Seed), Investors in Health IT (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed), Investors in AI (Seed), Investors in AutoTech (Series A), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in AutoTech (Series A), Investors in Generative Tech/AI (Series A), Investors in Enterprise Applications (Series A), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series A), Investors in Enterprise Applications (Series A), Investors in Digital Health (Series A), Investors in Generative Tech/AI (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in AutoTech (Series A), Investors in Enterprise (Series A), Investors in AI (Series A), Investors in SaaS (Series A), Investors in SaaS (Series A), Investors in Enterprise (Series A), Investors in AI (Series A), Investors in Generative Tech/AI (Series A), Investors in Digital Health (Series A), Investors in Consumer Health (Series A), Investors in Enterprise Applications (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in AI (Series A), Investors in SaaS (Series A), Investors in Enterprise (Series A), Investors in Consumer Health (Series B), Investors in Enterprise Applications (Series B), Investors in Health IT (Series B), Investors in AutoTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in AutoTech (Series B), Investors in Enterprise Applications (Series B), Investors in Digital Health (Series B), Investors in Generative Tech/AI (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Series B), Investors in Generative Tech/AI (Series B), Investors in Health IT (Series B), Investors in Enterprise (Series B), Investors in SaaS (Series B), Investors in AutoTech (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in SaaS (Series B), Investors in AI (Series B), Investors in Generative Tech/AI (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Enterprise Applications (Series B), Investors in AI (Series B), Investors in SaaS (Series B), Investors in Enterprise (Series B), Investors in Canada (Other Lists), Investors in Female Investors (Other Lists), Investors in Israel (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in New York City (Other Lists)
Photo of Ludovic Andre, Managing Director at Crédit Mutuel Equity
Ludovic Andre
Crédit Mutuel Equity·Managing Director
Sweet spot: $5
Range: $3 - $15
Investors in United States, Investors in Canada
Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Enterprise Applications (Series A), Investors in Analytics (Series A), Investors in E-commerce (Series A), Investors in Cloud Infrastructure (Series A), Investors in DeepTech (Series A), Investors in Web3/Blockchain (Series A), Investors in SaaS (Series A), Investors in AI (Series A), Investors in DeepTech (Series A), Investors in Analytics (Series A), Investors in Enterprise Applications (Series A), Investors in E-commerce (Series A), Investors in Web3/Blockchain (Series A), Investors in Cloud Infrastructure (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in SaaS (Series A), Investors in AI (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Enterprise Applications (Series B), Investors in Cloud Infrastructure (Series B), Investors in DeepTech (Series B), Investors in Analytics (Series B), Investors in Web3/Blockchain (Series B), Investors in E-commerce (Series B), Investors in AI (Series B), Investors in SaaS (Series B), Investors in DeepTech (Series B), Investors in Analytics (Series B), Investors in Enterprise Applications (Series B), Investors in Web3/Blockchain (Series B), Investors in Cloud Infrastructure (Series B), Investors in E-commerce (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in AI (Series B), Investors in SaaS (Series B), Investors in Canada (Other Lists)
Photo of Daniella Kranjac, General Partner at Avant Bio LLC
Daniella Kranjac
Avant Bio LLC·General Partner
Sweet spot: $5.0M
Range: $3.0M - $10.0M
Investors in Switzerland, Investors in United Kingdom, Investors in Europe, Investors in Canada, Investors in United States
Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Canada (Other Lists), Investors in Female Investors (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists)
Photo of Jeffrey Kadanoff, Partner
Jeffrey Kadanoff
Partner
Sweet spot: $3.0M
Range: $500K - $10.0M
Investors in Israel, Investors in Europe, Investors in Canada, Investors in United States
Photo of Eric Blondeel, Venture Partner at Pioneer Fund
Eric Blondeel
Pioneer Fund·Venture Partner
Sweet spot: $250K
Range: $200K - $300K
Investors in Canada
Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Canada (Other Lists)
Photo of Steven Woods, Partner at iNovia Capital
Steven Woods
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Canada
Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in AI (Seed), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in AI (Seed), Investors in Health & Hospital Services (Seed), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in AI (Series A), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in AI (Series B), Investors in Health & Hospital Services (Series B), Investors in Canada (Other Lists)
Photo of Carl Choi, Principal at Solasta Ventures
Carl Choi
Solasta Ventures·Principal
Sweet spot: $5.0M
Range: $1M - $10.0M
Investors in Europe, Investors in Canada, Investors in SF Bay Area (CA)
Investors in AR/VR (Series A), Investors in Entertainment & Sports (Series A), Investors in Gaming/eSports (Series A), Investors in Analytics (Series A), Investors in Digital Health (Series A), Investors in Marketplaces (Series A), Investors in Enterprise (Series A), Investors in FinTech (Series A), Investors in AI (Series A), Investors in Entertainment & Sports (Series A), Investors in AR/VR (Series A), Investors in Gaming/eSports (Series A), Investors in AR/VR (Series A), Investors in Analytics (Series A), Investors in Entertainment & Sports (Series A), Investors in Digital Health (Series A), Investors in Future of Work (Series A), Investors in Gaming/eSports (Series A), Investors in Marketplaces (Series A), Investors in Analytics (Series A), Investors in FinTech (Series A), Investors in AI (Series A), Investors in Enterprise (Series A), Investors in Marketplaces (Series A), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in Enterprise (Series A), Investors in FinTech (Series A), Investors in AR/VR (Series B), Investors in Entertainment & Sports (Series B), Investors in Gaming/eSports (Series B), Investors in Digital Health (Series B), Investors in Analytics (Series B), Investors in Marketplaces (Series B), Investors in Enterprise (Series B), Investors in FinTech (Series B), Investors in AI (Series B), Investors in Entertainment & Sports (Series B), Investors in AR/VR (Series B), Investors in Gaming/eSports (Series B), Investors in Analytics (Series B), Investors in AR/VR (Series B), Investors in Entertainment & Sports (Series B), Investors in Future of Work (Series B), Investors in Gaming/eSports (Series B), Investors in Digital Health (Series B), Investors in Marketplaces (Series B), Investors in Analytics (Series B), Investors in AI (Series B), Investors in FinTech (Series B), Investors in Marketplaces (Series B), Investors in Enterprise (Series B), Investors in Digital Health (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in FinTech (Series B), Investors in Canada (Other Lists), Investors in Diverse Investors (Other Lists), Investors in San Francisco Bay Area (Other Lists)